Modeling HIV-1 Neuropathogenesis and neuronal dysregulation using 3D-organoids containing multiple CNS cell lineages
Modeling HIV-1 Neuropathogenesis and neuronal dysregulation using 3D-organoids containing multiple CNS cell lineages
批准号:
10651458
负责人:
VELPANDI AYYAVOO
金额:
$68.63万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-15 至 2024-08-31
关键词:
3-DimensionalAIDS dementiaAddressAffectAgonistAstrocytesAstrocytosisBrainCell LineageCellsCentral Nervous System DiseasesChronicClinicalCognitionDendritesDevelopmentDiseaseDisease ManagementDrug abuseElectrophysiology (science)EnvironmentEquilibriumEvaluationExhibitsGoalsHIVHIV InfectionsHIV-1HIV-associated neurocognitive disorderHumanImmuneImpaired cognitionIn VitroIndividualInfectionInflammationKnock-outLeadMediatingMicrogliaModelingMolecularMorphineMorphologyNerve DegenerationNeurogliaNeuronal DysfunctionNeuronal InjuryNeuronsNeuropathogenesisOpioidOrganoidsPain managementPathologicPathologyPatientsPersonsPharmaceutical PreparationsPhysiologicalPopulationProcessRNA InterferenceResearchResearch PersonnelRoleSubstance Use DisorderSymptomsSynapsesSynaptic plasticitySystemTestingTherapeuticViralViral Load resultViral ProteinsVirusVirus Replicationantiretroviral therapyastrogliosisbrain dysfunctioncell typecomorbiditydrug of abusefrontal lobeillicit drug useimprovedin vitro Modelmacrophagemu receptorsmutantneuroinflammationneuron lossneuronal survivalneurotoxicnovelnovel therapeuticsopioid epidemicpreventrelease factorsynaptic functionsynaptic pruningtherapeutic developmentthree dimensional cell culturevirology
中文摘要
项目摘要
HIV相关的神经认知障碍(HAND)的范围从轻度到严重的认知缺陷,
超过60%的HIV-1受试者接受联合抗逆转录病毒治疗(cART)。病理学评价
HIV-1阳性受试者的额叶皮质显示存在HIV-1感染的神经炎症
小胶质细胞/巨噬细胞、星形胶质细胞增生、树突损失和神经元中的突触修剪。的降解
伴随这些神经元变化的树突导致突触丧失、神经元和认知能力下降,
这导致艾滋病毒感染者发生HAND。此外,这些影响可能会因以下因素而加剧:
非法药物使用滥用,如阿片类药物,这是这一人群经常滥用的药物,因此,
越来越需要研究HAND和了解HIV相关的神经发病机制,以开发更好的治疗方法
选择和改善疾病管理。然而,这些努力由于缺乏一个
生理学相关的脑/CNS模型。为了满足这一需求,我们开发了一种尖端的三文化人类
包含初级神经元、星形胶质细胞和小胶质细胞的3D脑类器官(hBORG)(HIV-1感染和
未感染)来精确地模拟大脑环境、慢性病毒复制和神经炎症环境
在HIV-1感染者中观察到。使用这个3D-BORG模型,我们建议测试我们的假设,
由HIV-1感染的小胶质细胞引起的神经炎症,诱导神经元变性,突触修剪和
树突的丧失、星形细胞增多症以及这些作用因阿片类药物滥用而恶化。我们建议
为实现这些目标,我们采取了以下措施:目标1。描述受感染的小胶质细胞如何有助于修剪和缩放
突触树突、突触功能丧失和神经元丧失;目的2.确定如何使用非法药物,例如
吗啡驱动神经元功能障碍和病理学的发展和/或恶化;以及目的3.
确定来自HIV-1感染的小胶质细胞的病毒和细胞因子如何引起HAND相关的病理性
功能.我们已经组建了一个研究团队,他们在HIV-1病毒学,3D类器官和
因此,药物滥用和突触功能将决定受感染的小胶质细胞如何与神经元相互作用,
星形胶质细胞,并进一步描绘参与树突状细胞损伤,突触可塑性,
存在和不存在药物滥用时的神经元存活。这将帮助我们开发新的疗法,
可以预防神经元损伤和突触功能丧失以及在PLWH中观察到的认知障碍。
英文摘要
Project Summary
HIV-associated neurocognitive disorder (HAND) range from mild to severe deficits in cognition and occurs in
more than 60% of HIV-1 subjects receiving combined antiretroviral therapy (cART). Pathological evaluation of
the frontal cortex of HIV-1 positive subjects revealed neuroinflammation with presence of HIV-1 infected
microglia/macrophages, astrogliosis, dendrites loss and synaptic pruning in neurons. The degradation of
dendrites that accompany these neuronal changes leads to synaptic loss, neuronal and cognitive decline, and
this causes development of HAND in people living with HIV. Moreover, these effects may be exacerbated by
illicit drug use abuse such as opioids, a drug commonly abused by this population, thus, there is a great and
increasing need to study HAND and understand HIV-associated neuropathogenesis to develop better treatment
options and improve disease management. However, these efforts are significantly hampered by the lack of a
physiologically relevant brain/CNS model. To address this need, we developed a cutting-edge tri-culture human
3D-brain organoids (hBORGs) that contains primary neurons, astrocytes and microglia (HIV-1-infected and
uninfected) to accurately model the brain environment, chronic virus replication, and neuroinflammatory milieu
observed in HIV-1 infected individuals. Using this 3D-BORG model, we propose to test our hypothesis that
neuroinflammation caused by HIV-1 infected microglia, induces degeneration of neurons, synaptic pruning and
loss of dendrites, astrocytosis and these effects worsen by the addition of oipoid drug abuse. We propose the
following aims to achieve the goals: Aim 1. Delineate how infected microglia contribute to pruning and scaling of
synaptodendrites, loss of synaptic functions and neuronal loss; Aim 2. Determine how use of illicit drugs such as
Morphine drives the development and/or worsening of the neuronal dysfunction and pathology; and Aim 3.
Identify the how viral and cellular factors from HIV-1 infected microglia cause the HAND-associated pathological
features. We have assembled a team of investigators who have expertise in HIV-1 Virology, 3D-Organoids and
drug abuse and synaptic function, thus, are poised to define how infected microglia interact with neurons and
astrocytes and further delineate the molecular mechanisms involved in dendritic damage, synaptic plasticity and
neuronal survival in the presence and absence of drug abuse. This will help us develop novel therapeutics that
can prevent neuronal damage and loss of synaptic function and cognitive impairment observed in PLWH.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8432453
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:7929088
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8619524
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8041009
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
HIV-1 Associated Dementia: Concomitant Roles of Vpr and Cellular Factors
-
批准号:8220888
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2010
-
负责人:VELPANDI AYYAVOO
-
依托单位:
Project 3
-
批准号:7507623
-
项目类别:
-
资助金额:$15.73万
-
财政年份:2007
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6627836
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6496565
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6791675
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6722806
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:6875678
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2002
-
负责人:VELPANDI AYYAVOO
-
依托单位:
IMMUNOPATHOLOGY OF HIV-1 VPR
-
批准号:7417646
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2001
-
负责人:VELPANDI AYYAVOO
-
依托单位:
NOVEL VECTOR DESIGN TO EXPRESS MULTIPLE ANTIGENS
-
批准号:6374714
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2000
-
负责人:VELPANDI AYYAVOO
-
依托单位:
NOVEL VECTOR DESIGN TO EXPRESS MULTIPLE ANTIGENS
-
批准号:6339775
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2000
-
负责人:VELPANDI AYYAVOO
-
依托单位:
Project 3
-
批准号:7671236
-
项目类别:
-
资助金额:$20.03万
-
财政年份:--
-
负责人:VELPANDI AYYAVOO
-
依托单位:
海外基金